Wan, Shanshan

Cancer mediates effector T cell dysfunction by targeting microRNAs and EZH2 via glycolysis restriction

Zhao, E., Maj, T., Kryczek, I., Li, W., Wu, K., Zhao, L., Wei, S., Crespo, J., Wan, S., Vatan, L., et al. (2016) · Nature Immunology

Cancer Immunotherapy and BiomarkersCancer, Hypoxia, and Metabolism

Cited by 405

CD4+ T lymphocyte ablation prevents pancreatic carcinogenesis in mice

Zhang, Y., Yan, W., Mathew, E., Bednar, F., Wan, S., Collins, M. A., Evans, R. A., Welling, T. H., Vonderheide, R. H., & di Magliano, M. P. (2014) · Cancer Immunology Research

Pancreatic and Hepatic Oncology ResearchT-cell and B-cell Immunology

Cited by 102

Targeting ADAM17 inhibits human colorectal adenocarcinoma progression and tumor‐initiating cell frequency

Dosch, J., Ziemke, E., Wan, S., Luker, K., Welling, T., Hardiman, K., Fearon, E., Thomas, S., Flynn, M., Rios-Doria, J., et al. (2017) · Oncotarget

Protease and Inhibitor MechanismsCancer Cells and Metastasis

Cited by 40